FDA Inspection 1211536 — Firas B. Badin, M.D.

Firas B. Badin, M.D. — FEI 3027314202

The FDA completed an inspection of Firas B. Badin, M.D. on August 4, 2023 in Lexington, KY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 4, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Lexington, KY (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
751721 CFR 312.66Initial and continuing review
756021 CFR 312.60FD-1572, protocol compliance